Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-Term Observation of Patients With Cancer - an Entity-Independent Registry for Healthcare and Translational Research at the University Medicine Dresden (Cancer-Reg-VT).
Datzmann T, Schoffer O, Schmitt J, Böhme H, Fritzmann J, Distler M, Ubbelohde U, Giehl-Brown E, Henke T, Krause M, Glimm H, Bornhäuser M, Weitz J. Datzmann T, et al. Among authors: krause m. Gesundheitswesen. 2023 Sep;85(S 03):S226-S234. doi: 10.1055/a-2129-7651. Epub 2023 Sep 26. Gesundheitswesen. 2023. PMID: 37751759 Free article. English, German.
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
Zschaeck S, Hofheinz F, Zöphel K, Bütof R, Jentsch C, Schmollack J, Löck S, Kotzerke J, Baretton G, Weitz J, Baumann M, Krause M. Zschaeck S, et al. Among authors: krause m. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1813-1822. doi: 10.1007/s00259-017-3742-0. Epub 2017 Jun 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28600646
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model.
Pishali Bejestani E, Cartellieri M, Bergmann R, Ehninger A, Loff S, Kramer M, Spehr J, Dietrich A, Feldmann A, Albert S, Wermke M, Baumann M, Krause M, Bornhäuser M, Ehninger G, Bachmann M, von Bonin M. Pishali Bejestani E, et al. Among authors: krause m. Oncoimmunology. 2017 Jun 20;6(10):e1342909. doi: 10.1080/2162402X.2017.1342909. eCollection 2017. Oncoimmunology. 2017. PMID: 29123951 Free PMC article.
Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer.
Jarosch A, Sommer U, Bogner A, Reißfelder C, Weitz J, Krause M, Folprecht G, Baretton GB, Aust DE. Jarosch A, et al. Among authors: krause m. Oncoimmunology. 2017 Nov 7;7(2):e1393133. doi: 10.1080/2162402X.2017.1393133. eCollection 2018. Oncoimmunology. 2017. PMID: 29308324 Free PMC article.
Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer.
Wagner F, Hölig U, Wilczkowski F, Plesca I, Sommer U, Wehner R, Kießler M, Jarosch A, Flecke K, Arsova M, Tunger A, Bogner A, Reißfelder C, Weitz J, Schäkel K, Troost EGC, Krause M, Folprecht G, Bornhäuser M, Bachmann MP, Aust D, Baretton G, Schmitz M. Wagner F, et al. Among authors: krause m. Front Immunol. 2019 Mar 29;10:602. doi: 10.3389/fimmu.2019.00602. eCollection 2019. Front Immunol. 2019. PMID: 30984181 Free PMC article.
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial.
Fasslrinner F, Schetelig J, Burchert A, Kramer M, Trenschel R, Hegenbart U, Stadler M, Schäfer-Eckart K, Bätzel M, Eich H, Stuschke M, Engenhart-Cabillic R, Krause M, Dreger P, Neubauer A, Ehninger G, Beelen D, Berdel WE, Siepmann T, Stelljes M, Bornhäuser M. Fasslrinner F, et al. Among authors: krause m. Lancet Haematol. 2018 Apr;5(4):e161-e169. doi: 10.1016/S2352-3026(18)30022-X. Epub 2018 Mar 14. Lancet Haematol. 2018. PMID: 29550384 Clinical Trial.
Human gastric cancer modelling using organoids.
Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Grützmann K, Sommer U, Schweitzer C, Schölch S, Uhlemann H, Gaebler AM, Werner K, Krause M, Baretton GB, Welsch T, Koo BK, Aust DE, Klink B, Weitz J, Stange DE. Seidlitz T, et al. Among authors: krause m. Gut. 2019 Feb;68(2):207-217. doi: 10.1136/gutjnl-2017-314549. Epub 2018 Apr 27. Gut. 2019. PMID: 29703791 Free PMC article.
Research Facility for Radiobiological Studies at the University Proton Therapy Dresden.
Beyreuther E, Baumann M, Enghardt W, Helmbrecht S, Karsch L, Krause M, Pawelke J, Schreiner L, Schürer M, von Neubeck C, Lühr A. Beyreuther E, et al. Among authors: krause m. Int J Part Ther. 2018 Summer;5(1):172-182. doi: 10.14338/IJPT-18-00008.1. Epub 2018 Sep 21. Int J Part Ther. 2018. PMID: 31773028 Free PMC article.
Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms.
Pape K, Lößner AJ, William D, Czempiel T, Beyreuther E, Klimova A, Lehmann C, Schmäche T, Merker SR, Naumann M, Ada AM, Baenke F, Seidlitz T, Bütof R, Dietrich A, Krause M, Weitz J, Klink B, von Neubeck C, Stange DE. Pape K, et al. Among authors: krause m. Cancers (Basel). 2022 Oct 11;14(20):4984. doi: 10.3390/cancers14204984. Cancers (Basel). 2022. PMID: 36291768 Free PMC article.
2,148 results